

Adcock Ingram Pharma Profile
Key Indicators
- Authorised Capital ₹ 60.50 Cr
- Paid Up Capital ₹ 60.50 Cr
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 50.50 Cr
- Revenue Growth -88.45%
- Profit Growth -344.67%
- Ebitda -10.01%
- Net Worth 107.11%
- Total Assets 108.86%
About Adcock Ingram Pharma
Adcock Ingram Pharma Private Limited (AIPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2021 (Three years and 11 months 3 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 60.50 Cr and a paid-up capital of Rs 60.50 Cr.
The company currently has active open charges totaling ₹50.50 Cr.
The Key Managerial Personnel (KMP) at Adcock Ingram Pharma Private Limited India are Alok Sharma as COMPANY SECRETARY and Chandra Mohan as Cfo. Ammanna Yarlagadda, Shanthakumarie Pather, Yudhveer Singh, and Four other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299KA2021PTC148184
- Company No.
148184
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2021
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Adcock Ingram Pharma?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Alok Sharma | Company Secretary | 21-Jun-2022 | Current |
Ammanna Yarlagadda ![]() | Managing Director | 21-Sep-2022 | Current |
Chandra Mohan | CFO | 02-Aug-2023 | Current |
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yasuhiro Nakagiri ![]() | Additional Director | 20-Jun-2024 | Current |
Pravin Iyer ![]() | Director | 07-Jun-2021 | Current |
Pankaj Garg ![]() | Director | 07-Jun-2021 | Current |
Shanthakumarie Pather ![]() | Director | 28-Sep-2022 | Current |
Yudhveer Singh ![]() | Director | 24-Jan-2022 | Current |
Kenshi Murase ![]() | Director | 11-Jun-2021 | Current |
Financial Performance of Adcock Ingram Pharma.
Adcock Ingram Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 88.45% decrease. The company also saw a substantial fall in profitability, with a 344.67% decrease in profit. The company's net worth Soared by an impressive increase of 107.11%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Adcock Ingram Pharma?
In 2023, Adcock Ingram Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Adcock Ingram Limited
Alok Sharma, Ammanna Yarlagadda and 6 more are mutual person
- Medreich Limited
Kenshi Murase, Pankaj Garg and 1 more are mutual person
- Medreich Life Care Limited
Pankaj Garg is a mutual person
- Relicare Tech Services Private Limited
Pravin Iyer is a mutual person
Charges (Loans)
₹50.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 50.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
08 Mar 2022 | Others | ₹50.50 Cr | Open |
How Many Employees Work at Adcock Ingram Pharma?
Adcock Ingram Pharma has a workforce of 67 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Adcock Ingram Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adcock Ingram Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Adcock Ingram Pharma
Recent activity within the organization
- Annual General Meeting
Adcock Ingram Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
- Director Appointment
Yasuhiro Nakagiri was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2024 & has been associated with this company since 10 months 20 days .
- Balance Sheet
Adcock Ingram Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Charges
A charge with Others of Rs. 50.50 Cr registered on 08 Mar 2022 with Charge ID 100553591 was modified on 08 Dec 2023.
- Director Appointment
Shanthakumarie Pather was appointed as a Director was appointed as a Director on 28 Sep 2022 & has been associated with this company since 2 years 7 months .
- Director Appointment
Ammanna Chowdary Yarlagadda was appointed as a Managing Director was appointed as a Managing Director on 21 Sep 2022 & has been associated with this company since 2 years 7 months .
Frequently asked questions
What is the Incorporation or founding date of Adcock Ingram Pharma Private Limited?
Adcock Ingram Pharma Private Limited was incorporated on 07 Jun 2021.
What is authorized share capital and paid-up capital of Adcock Ingram Pharma Private Limited?
The authorized share capital of Adcock Ingram Pharma Private Limited is ₹ 60.50 Cr and paid-up capital is ₹ 60.50 Cr.
Who are the current board members & directors of Adcock Ingram Pharma Private Limited?
Currently 9 directors are associated with Adcock Ingram Pharma Private Limited.
- Alok Sharma
- Ammanna Chowdary Yarlagadda
- Shanthakumarie Pather
- Yudhveer Singh
- Kenshi Murase
- Pankaj Garg
- Pravin Vaidyanathan Iyer
- Yasuhiro Nakagiri
- Chandra Mohan
What is the registered address of Adcock Ingram Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Adcock Ingram Pharma Private Limited is 41/42, Bommasandra Industrial Area Anekal Taluk India, Bengaluru, Karnataka, 560099.
What is the corporate identification number (CIN) and company number of Adcock Ingram Pharma Private Limited?
The corporate identification number (CIN) of Adcock Ingram Pharma Private Limited is U24299KA2021PTC148184 and the company number is 148184 as per Ministry of Corporate Affairs (MCA).
What is the official website of Adcock Ingram Pharma Private Limited?
The Official website of Adcock Ingram Pharma Private Limited is https://www.medreich.com
What has been the recent revenue trend for Adcock Ingram Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Adcock Ingram Pharma Private Limited has fallen by -88.45%.
How many employees does Adcock Ingram Pharma Private Limited currently have?
As Per 2023 financial reports, 67 employees are currently employed by Adcock Ingram Pharma Private Limited.
What change has been observed in the net worth of Adcock Ingram Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Adcock Ingram Pharma Private Limited has experienced an upsurge of 107.11%.
What are the total open charges for Adcock Ingram Pharma Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Adcock Ingram Pharma Private Limited amount to ₹ 50.50 Cr.
When was the last Balance Sheet of Adcock Ingram Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Adcock Ingram Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
GR
Gundala RamireddyDirectorMC
Mahendra ChibabhaiAdditional DirectorKH
Kensuke HataDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India